Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Non-Current Deffered Revenue (2021 - 2022)

Intelligent Bio Solutions has reported Non-Current Deffered Revenue over the past 2 years, most recently at $1.6 million for Q4 2022.

  • Quarterly results put Non-Current Deffered Revenue at $1.6 million for Q4 2022, up 35.39% from a year ago — trailing twelve months through Dec 2022 was $1.6 million (up 35.39% YoY), and the annual figure for FY2022 was $1.1 million, down 65.29%.
  • Non-Current Deffered Revenue for Q4 2022 was $1.6 million at Intelligent Bio Solutions, down from $2.6 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for INBS hit a ceiling of $3.1 million in Q2 2021 and a floor of $1.1 million in Q2 2022.